Metabolomics may enable early diagnosis, treatment in macular degeneration

Investigators reported that patients with age-related macular degeneration have a distinct plasma metabolomic profile compared with controls, according to research presented at the American Society of Retina Specialists annual meeting.
“Age-related macular degeneration is a leading cause of blindness in the world, yet there are several very important unmet needs for this multifactorial disease, which includes lack of complete understanding of disease pathogenesis, lack of accessible and reliable biomarkers for diagnosis and prognosis, and lack of treatments for all forms of dry AMD,”

Full Story →